West Pharmaceutical
287 hedge funds and large institutions have $5.69B invested in West Pharmaceutical in 2016 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 94 increasing their positions, 100 reducing their positions, and 37 closing their positions.
35% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 37
16% more capital invested
Capital invested by funds: $4.91B → $5.69B (+$778M)
3% more funds holding
Funds holding: 278 → 287 (+9)
1.2% more ownership
Funds ownership: 90.47% → 91.68% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
6% less repeat investments, than reductions
Existing positions increased: 94 | Existing positions reduced: 100
100% less call options, than puts
Call options by funds: $8K | Put options by funds: $2.71M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$83.5M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$39.2M |
| 3 |
JP Morgan Chase
New York
|
+$38.1M |
| 4 |
Jennison Associates
New York
|
+$37.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$34.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Prudential Financial
Newark,
New Jersey
|
-$19.3M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$14.9M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$13.7M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
-$13.7M |
| 5 |
HIM
Hermes Investment Management
London Uk,
United Kingdom
|
-$13M |
WST Hedge Fund Activity: Q4 2016 in Review
287 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q4 2016, worth a combined $5.69B — up 16% from $4.91B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new WST positions and 37 closed out — a net gain of 13 holders — while 94 added to existing stakes and 100 trimmed.
The largest buyer was Millennium Management, adding an estimated $83.5M. The largest seller was Prudential Financial, cutting an estimated $19.3M.
- 287 institutional investors held West Pharmaceutical (WST) as of Q4 2016, up from 278 in Q3 2016.
- Funds reported $5.69B of West Pharmaceutical stock for Q4 2016, up 16% quarter-over-quarter.
- 50 funds opened new West Pharmaceutical positions in Q4 2016 and 37 closed out, a net change of +13 holders.
- The largest West Pharmaceutical buyer in Q4 2016 was Millennium Management, an estimated $83.5M added.
- The largest West Pharmaceutical seller in Q4 2016 was Prudential Financial, an estimated $19.3M sold.
Based on aggregated 13F filings for Q4 2016.